These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38291462)

  • 1. Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in silico and in vitro combination analysis.
    Nada AA; Metwally AM; Asaad AM; Celik I; Ibrahim RS; Eldin SMS
    BMC Complement Med Ther; 2024 Jan; 24(1):65. PubMed ID: 38291462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated
    Ghallab DS; Shawky E; Metwally AM; Celik I; Ibrahim RS; Mohyeldin MM
    RSC Adv; 2022 Jan; 12(5):2843-2872. PubMed ID: 35425287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytochemical Profile, Antioxidant, Enzyme Inhibition, Acute Toxicity, In Silico Molecular Docking and Dynamic Analysis of Apis Mellifera Propolis as Antidiabetic Supplement.
    Syaifie PH; Ibadillah D; Jauhar MM; Reninta R; Ningsih S; Ramadhan D; Arda AG; Ningrum DWC; Kaswati NMN; Rochman NT; Mardliyati E
    Chem Biodivers; 2024 Jun; 21(6):e202400433. PubMed ID: 38584139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
    Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
    BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug screening of α-amylase inhibitors as candidates for treating diabetes.
    Alp M; Misturini A; Sastre G; Gálvez-Llompart M
    J Cell Mol Med; 2023 Aug; 27(15):2249-2260. PubMed ID: 37403218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
    Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
    Tolmie M; Bester MJ; Apostolides Z
    J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro
    Algethami FK; Saidi I; Abdelhamid HN; Elamin MR; Abdulkhair BY; Chrouda A; Ben Jannet H
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies.
    Zareei S; Ranjbar S; Mohammadi M; Ghasemi Y; Golestanian S; Avizheh L; Moazzam A; Larijani B; Mohammadi-Khanaposhtani M; Tarahomi MM; Mahdavi M; Sadeghian N; Taslimi P
    Bioorg Chem; 2023 Dec; 141():106846. PubMed ID: 37713948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
    Riyaphan J; Pham DC; Leong MK; Weng CF
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
    Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
    J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
    Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
    Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.